Positron emission tomography (PET) with F-18 FDG of adrenal masses: Comparison between benign and malignant lesions;La tomografia con emissione di positroni (PET) con F-18 FDG nello studio delle formazioni espansive con sede surrenalica: Confronto tra lesioni benigne e maligne

Radiologia Medica

Volumn 92, Issue 6, 1996, Pages 782-787

  Maurea, Simone ^a,b   Mainolfi, Ciro ^a   Wang, Hui ^a   Varrella, Paola ^a   Panico, Maria Rosaria ^a   Klain, Michele ^a   Rossi, Riccardo ^a   Cremona, Francesco ^a   Bazzicalupo, Lucio ^a   Salvatore, Marco ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE   (Italy)

Author keywords

adrenal gland, tumors; adrenal tumors, F 18 FDG; adrenal tumors, PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADRENAL CANCER; ADRENAL GLAND EXAMINATION; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY;

EID: 12644300661     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Boland GW, Goldberg MA, Lee MJ e Coll: Indeterminate adrenal mass in patients with cancer. evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 194: 131-134, 1995
2. Copeland PM: The incidentally discovered adrenal mass. Ann Intern Med 98: 940-945, 1983.
3. Di Chiro G, Dela Par RL, Brooks RA e Coll: Glucose utilization of cerebral gliomas measured by 18-F-fluoro-deoxyglucose and positron emission tomography. Neurology 32: 1323-1329, 1982.
4. Falke THM, Sandler MP: Classification of silent adrenal masses: time to get practical. J Nucl Med 35: 1152-1154, 1994.
5. Francis IR, Gross MD, Shapiro B e Coll: Integrated imaging of adrenal disease. Radiology 184: 1-13, 1992
6. Gross MD, Shapiro B: Clinical review 50 Clinically silent adrenal masses. J Clin Endocr Metabol 77: 885-888, 1993.
7. Gross MD, Shapiro B, Francis IR e Coll: Scintigraphic evaluation of clinically silent adrenal masses. J Nucl Med 35: 1145-1152, 1994
8. Hatanaka M: Transport of sugars in tumor cell membranes. Biochem Biophys Acta 355. 77-104, 1974.
9. Kubota K, Malsuzawa T, Fujiwara T e Coll: Differential diagnosis of lung tumor with positron emission tomography: a prospective study J Nucl Med 31: 1927-1933, 1990.
10. 123I metaiodobenzylguanidine imaging. Clin Nucl Med 20: 22-24, 1995.
11. Maurea S, Klain M, Lastoria S e Coll: Carattenzzazione scintigrafica delle lesioni espansive a sede surrenalica: confronto con l'imaaing a Risonanza Magnetica. Radiol Med 90. 756-765, 1995.
12. Newman JS, Francis IR, Kaminski MS e Coll: Imaging of lymphoma with PET with 2-F-18-fluoro-2-deoxy-D-glucose: correlation with CT. Radiology 190: 111-116, 1994.
13. Nolop KB, Rhodes CG, Brudin LH e Coll: Glucose utilization in vivo by human pulmonary neoplasm. Cancer 60: 2682-2689, 1987.
14. Ross, MS, Aron DC: Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N Engl J Med 323: 1402-1405, 1990
15. Rufini V, Troncone L, Daidone MS e Coll: Contributo della medicina nucleare nella diagnostica delle masse sutrenaliche silenti. Radiol Med 87: 319-326, 1994.
16. Silverman SG, Mueller PR, Pinkney LP e Coll: Predictive value of imageguided adrenal biopsy: analysis of results of 101 biopsies. Radiology 187: 715-719, 1993.
17. Yankaskas BC, Staab EV, Cravem MB e Coll: Delayed complications from fine-needle biopsies of solid masses of the abdomen. Invest Radiol 21: 325-328, 1986.
18. Wahl RL, Hawkins RA, Larson SM e Coll: Proceeding of a national cancer institute workshop: PET in oncology - A clinical research agenda Radiology 193: 604-606, 1994.
19. Wahl RL, Hutchins GD, Buchsboaum DJ e Coll: 18-F-2-deoxy-2-fluoro-deoxy-glucose uptake into human tumor xenografts. Cancer 67: 1544-1550, 1991.
20. Warburg O: On the origin of cancer cells. Science 123: 309-314, 1956.
21. Weinhous S: Changing perceptions of carbohydrate metabolism in tumors. In: Arnott MS, Van Eys SJ, Wary JM (eds): Molecular interrelations of nutrition and cancer, pag 167-181 New York, Raven Press, 1981.